CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells-Reference-Cited by-同舟云学术

CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells

Published:2020-04-11 Issue:9 Volume:24 Page:5135-5145
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Cao Yingxiao¹^ORCID,Li Xin²,Kong Shiqi¹,Shang Shuling³,Qi Yanhui⁴

Affiliation:

1. Department of Neurosurgery Xingtai People’s Hospital Xingtai China

2. Department of Neurosurgery The First People's Hospital of Shenyang Shenyang China

3. Department of Operating Room Xingtai People’s Hospital Xingtai China

4. Department of Intensive Care Unit Xingtai People’s Hospital Xingtai China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.15156

Reference49 articles.

1. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment;Hanif F;Asian Pac J Cancer Prev,2017

2. Newly diagnosed glioblastoma: a review on clinical management;Lukas RV;Oncology (Williston Park),2019

3. Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials

4. Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues

5. Current Challenges and Opportunities in Treating Glioblastoma

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics Analysis of Interactions between Drug-Resistant and Drug-Sensitive Cancer Cells: Comparative Studies of Monoculture and Coculture Cell Systems;Journal of Proteome Research;2024-06-22

2. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate;Cell Communication and Signaling;2024-01-11

3. Enhancing drug delivery with supramolecular amphiphilic macrocycle nanoparticles: selective targeting of CDK4/6 inhibitor palbociclib to melanoma;Biomaterials Science;2024

4. Retraction: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells;Journal of Cellular and Molecular Medicine;2023-12-10

5. Enhancing Drug Delivery with Supramolecular Amphiphilic Macrocycle Nanoparticles: Selective Targeting of CDK4/6 Inhibitor Palbociclib to Melanoma;2023-11-21